JTF INTL (09689): Li Guofa Appointed as Independent Non-Executive Director
JTF INTL (09689) announced that Mr. Li Guofa has been appointed as an independent non-executive director, the chairman of the remuneration committee of the board of directors, and a member of each of the audit committee and the nomination committee of the board of directors, with effect from September 18, 2026.
JTF INTL (09689) announced that Mr. Li Guofa has been appointed as an independent non-executive director, chairman of the remuneration committee of the board of directors, and a member of each of the audit committee and nomination committee of the board of directors, with effect from September 18, 2026.
Following Mr. Li's appointment as an independent non-executive director, he has also been appointed as a member of the audit committee and the nomination committee, and as chairman of the remuneration committee, with effect from September 18, 2026. Mr. Xu Xingshan (former chairman of the remuneration committee) has been re-designated as a member of the remuneration committee. Save as disclosed above, there are no other changes to the composition of the board committees.
Related Articles

Zhejiang CFMOTO Power (603129.SH) plans to launch a 2026 stock option and restricted stock incentive plan.

DL HOLDINGS GP (01709) repurchased 2 million shares for HK$1.74 million on September 18.

Newland Pharmaceutical (301277.SZ): Moxifloxacin hydrochloride API obtains CEP certificate
Zhejiang CFMOTO Power (603129.SH) plans to launch a 2026 stock option and restricted stock incentive plan.

DL HOLDINGS GP (01709) repurchased 2 million shares for HK$1.74 million on September 18.

Newland Pharmaceutical (301277.SZ): Moxifloxacin hydrochloride API obtains CEP certificate

RECOMMEND





